Clinical trials
Observational Bruxism trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 8 |
| 2024 | 9 |
| 2025 | 11 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Unknown status | 13 |
| Not yet recruiting | 6 |
| Enrolling by invitation | 4 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cairo University | 4 |
| Akdeniz University | 2 |
| Ankara Yildirim Beyazıt University | 2 |
| Bandırma Onyedi Eylül University | 2 |
| Postgraduate Institute of Dental Sciences Rohtak | 2 |
| Abant Izzet Baysal University | 1 |
| Ahram Canadian University | 1 |
| Ain Shams University | 1 |
| Al-Hawash Private University | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bruxism | 53 |
| Temporomandibular Joint Disorders | 13 |
| Sleep Bruxism | 5 |
| Periodontitis | 4 |
| Anxiety Disorders | 3 |
| Sleep Initiation and Maintenance Disorders | 3 |
| Dental Caries | 2 |
| Fibromyalgia | 2 |
| Gingival Recession | 2 |
| Respiratory Aspiration | 2 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.